Paolo Pucci - 04 May 2026 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Reporting relationship: Director
Issuer ticker: WST
Reported as of: 04 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 May 2026, 17:37:23 UTC
Prior SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Louis Lalli, as an agent for Paolo Pucci

Key filing fact

Paolo Pucci filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 06 May 2026.

Key facts

This page summarizes Paolo Pucci's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 May 2026, 17:37.

Change

Previous filing in this sequence was filed on 07 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001436861 Primary reporting owner

Pucci Paolo

Relationship: Director
Address: 530 HERMAN O. WEST DRIVE, EXTON
Signature: /s/ Louis Lalli, as an agent for Paolo Pucci
Signature date: 06 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WST transaction

Common Stock

Award

Transaction value
Shares: +791
Change %: +7.1%
Price: $0.000000^*
Shares after: 11,854
Date: 04 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.